82 articles
Abbott Laboratories
Abbott Laboratories (ABT), founded 1888 by Wallace Calvin Abbott in Chicago, is a diversified healthcare company in medical devices, diagnostics, nutrition (Similac, Ensure, FreeStyle Libre), and branded generics, with 2025 sales of $44.3 billion.
AbbVie
AbbVie Inc. is an American research-based biopharmaceutical company headquartered in North Chicago, Illinois. Formed by Abbott Laboratories' 2013 spinoff, it is known for Humira and acquired Allergan in 2020.
Actavis
Actavis: Icelandic generics maker founded 1956 as Pharmaco, bought by Watson Pharmaceuticals in 2012 for $5.5 billion and adopted as the merged company's name; after Warner Chilcott, Forest, and Allergan acquisitions it renamed itself Allergan plc in 2015 and sold Actavis Generics to Teva for $40.5 billion.
Adar Poonawalla
Adar Poonawalla is an Indian businessman, CEO since 2011 of the Serum Institute of India, the world's largest vaccine maker, producing 1.5 billion doses a year for over 170 countries.
Albert Bourla
Albert Bourla, Greek-born veterinarian and Pfizer Chairman and CEO since January 2019, led development of the Pfizer-BioNTech COVID-19 vaccine (EUA December 11, 2020), the Seagen and Metsera acquisitions, and the Accord for a Healthier World.
Alex Gorsky
Alex Gorsky, American executive, West Point graduate and Army captain, was Chairman and CEO of Johnson & Johnson 2012-2021 and Executive Chairman 2022; later director at Apple, IBM, and JPMorgan Chase.
Allergan
Allergan plc, Irish pharmaceutical maker of Botox, Juvéderm, and Restasis, acquired by AbbVie on May 8, 2020 for $63 billion; its aesthetics business continues as Allergan Aesthetics, an AbbVie company.
Andrew Witty
Sir Andrew Witty, British executive, CEO of GlaxoSmithKline 2008-2017 and of UnitedHealth Group 2021-2025 after leading Optum; knighted, former Nottingham chancellor, stepped down May 2025.
Argenx
Argenx (argenx SE, ARGX) is a Dutch immunology biopharma founded in 2008, maker of VYVGART (efgartigimod), the first approved FcRn blocker for gMG, CIDP, and ITP, with $4.2 billion 2025 sales.
Arthur M. Sackler
Arthur M. Sackler (1913–1987), Brooklyn-born psychiatrist, pharmaceutical advertiser, Medical Tribune publisher, and Asian art collector; eldest Sackler brother, died before OxyContin, namesake of the Smithsonian Sackler Gallery.
AstraZeneca
AstraZeneca PLC, Anglo-Swedish pharmaceutical company formed 6 April 1999 by the Astra AB and Zeneca merger, headquartered in Cambridge, UK; 2025 revenue $58.7 billion, key drugs Farxiga, Tagrisso, Imfinzi, $80 billion 2030 ambition.
AtaiBeckley
AtaiBeckley (AtaiBeckley Inc., formerly ATAI Life Sciences) is a New York-based clinical-stage biotech formed in 2025 by the atai–Beckley Psytech merger, developing psychedelic neuroplastogens led by BPL-003 intranasal 5-MeO-DMT for treatment-resistant depression; acquired by Eli Lilly in 2026 for up to $3.8 billion.
Aurobindo Pharma
Aurobindo Pharma Limited (APL), Hyderabad-based Indian generic drug and API maker founded 1986 by P.V. Ramprasad Reddy and K. Nithyananda Reddy; top-2 Indian pharma by revenue, major US/Europe generics exporter, with recurring FDA warning letters (2019, 2022, Eugia 2025).
Barry Sherman
Barry Sherman (Bernard Sherman, 1942–2017), Canadian billionaire who founded generic drug maker Apotex in 1974; known for patent litigation, philanthropy, and his unsolved December 2017 murder with wife Honey in Toronto.
Bausch & Lomb
Bausch & Lomb (Bausch + Lomb), founded 1853 in Rochester, New York by John Jacob Bausch and Henry Lomb, is an eye health company making contact lenses, lens care, ophthalmic pharmaceuticals, and surgical devices; it introduced the first US mass-produced soft contact lens (SofLens, 1971) and IPO'd as BLCO in 2022.
Bausch Health
Bausch Health Companies Inc., formerly Valeant Pharmaceuticals, is a Laval, Quebec-based specialty pharmaceutical and medical device company with ~1,000 products in five segments, flagship drug Xifaxan, ~88% ownership of Bausch + Lomb, and 2025 revenue of $10,266 million.
Baxter International
Baxter International (NYSE: BAX), Deerfield, Illinois medical technology company founded 1931; largest US IV solutions maker via North Cove, NC plant (60% of supply); sold Kidney Care (Vantive) to Carlyle for $3.80B in 2025; Novum IQ pump recalls.
Bayer
Bayer AG, German life science company in Leverkusen with Pharmaceuticals, Consumer Health, and Crop Science divisions; founded 1863, maker of Aspirin, acquired Monsanto in 2018 for $63 billion, inheriting the Roundup glyphosate litigation.
Biotest AG
Biotest AG, now Biotest GmbH & Co. KGaA, is a German plasma-products company based in Dreieich, Germany, founded in 1946 and a subsidiary of Spain's Grifols since 2022.
Boehringer Ingelheim
Boehringer Ingelheim: German family-owned pharmaceutical company founded 1885 by Albert Boehringer in Ingelheim am Rhein; ~54,300 employees in 130 markets across Human Pharma, Animal Health, and biopharmaceutical contract manufacturing; acquired Merial from Sanofi in 2017.
Bristol Myers Squibb
Bristol Myers Squibb (BMY), formed by the 1989 Bristol-Myers and Squibb merger, is a Princeton, New Jersey biopharmaceutical company with $48.2 billion 2025 revenues, led by Eliquis and Opdivo, and CEO Chris Boerner.
Cardinal Health
Cardinal Health (NYSE: CAH), Dublin, Ohio healthcare distributor founded 1971 by Robert Walter; one of the Big Three US drug distributors with McKesson and Cencora; five operating segments, $63.7B Q4 FY2026 revenue, $26 billion opioid settlement participant.
Celgene
Celgene Corporation, Summit, New Jersey biotech founded 1986 by David Stirling and Sol Barer; rebuilt thalidomide as Thalomid, Revlimid, and Pomalyst for blood cancers; acquired by Bristol-Myers Squibb in November 2019 for $74 billion.
Charles Pfizer
Charles Pfizer (Karl Christian Friedrich Pfizer, 1824–1906), German-American chemist who co-founded Charles Pfizer & Company in Brooklyn in 1849 with cousin Charles Erhart, starting with a toffee-flavored santonin deworming candy and building a leading US fine-chemical maker.
Cipla
Cipla (Chemical, Industrial & Pharmaceutical Laboratories), Indian pharma company founded 1935 in Mumbai by K. A. Hamied; respiratory leader, $350/year AIDS drugs in 2001, FDA warning letters 2020 and 2023.
Click Therapeutics
Click Therapeutics is a New York City company developing prescription digital therapeutics, regulated software prescribed as medical treatment, and is known for Rejoyn, an app for depression symptoms.
Cyrus S. Poonawalla
Cyrus S. Poonawalla, Indian billionaire founder-chairman of Serum Institute of India (founded Pune, 1966), the world's largest vaccine maker by doses; Padma Bhushan 2022, Oxford honorary DSc 2019.
Dabur
Dabur, also known as Dabur India Limited, is an Indian consumer goods company founded by Dr. S. K. Burman in 1884, known for Ayurvedic products like Chyawanprash and Real.
Dilip Shanghvi
Dilip Shanghvi, born 1955 in Gujarat, is an Indian billionaire businessman who founded Sun Pharmaceutical Industries in 1983 with $200 borrowed from his father, receiving the Padma Shri in 2016.
Dr. Reddy's Laboratories
Dr. Reddy's Laboratories, Hyderabad-based Indian multinational pharma founded 1984 by Dr. K. Anji Reddy; NYSE-listed generics, APIs, biosimilars, and consumer health company with FY2026 revenue of ₹335.9 billion.